Im working with a major global biotech with a long-standing rare-disease portfolio is searching for a Director of Market Access & Channel Strategy to take ownership of U.S. access strategy across a portfolio of high-impact therapies. The incoming Director will step directly into a high-visibility, analytically intensive role that shapes pricing, distribution, and payer strategy for both existing and soon-to-launch products.
Why this role stands out
This is a unique opportunity to make your mark quickly :
- Youll work closely with a new, change-driven SVP who recently joined from the global business and is highly open to fresh thinking.
- Youll partner directly with a senior leader overseeing all U.S. rare disease market access, plus two additional therapeutic groups and the analytics team, creating a strong platform for influence.
- Youll shape strategy for an established inline portfolio in the immunology / rare disease space and guide multiple new launches, including an upcoming combination treatment and several future products and indications.
What You Will Lead
Youll own the core market access levers that determine how rare-disease therapies reach patients in the U.S. :
Setting pricing strategy for inline and pipeline assetsDesigning distribution and channel strategy across key U.S. pathwaysLeading contracting strategy in partnership with specialized pull-through teamsDeveloping payer-focused value messaging and evidence needsStress-testing existing approaches and identifying where the business needs to evolveSupporting brand planning, commercial readiness, and launch executionProviding market access input into pipeline development and future assetsThis is a role with plenty of structural support, including contracting teams, analytics, and commercial excellence, but the strategic direction will be yours to define.
What Theyre Looking For
The team wants someone who has :
U.S. market access experience (required)Experience in rare disease (strongly preferred)Pricing strategyDistribution strategyContracting strategyChannel strategyBoth inline and pipeline / launch experienceA track record of driving strategic change , challenging assumptions, and shaping strategy, not just executing itGlobal experience is a nice-to-have , not requiredWhy now?
The rare-disease business is entering a phase of significant expansion , with new launches, new indications, and new leadership ready to rethink how access strategy is built. This role will sit at the center of that change.If youre ready to step into a role that blends strategy, analysis, influence, and meaningful patient impact, this is an opportunity to genuinely shape the future of a growing U.S. portfolio.Compensation & Practicalities
Director levelSalary range : $174,500$274,230Internal equity typically $225K$240K , depending on experienceBonus : 26%LTI : ~$70,000Relocation : YesVisa sponsorship : Not at this time (due to urgency of start date)Full suite of competitive U.S. benefits